Clinical Trial Update: Biological Therapy in Treating Patients With Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a biological therapy for glioblastoma multiforme has been completed. The study status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Biological therapy

Snippet

Sponsor: The Cleveland Clinic | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED